Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2013 / Cilt: 39 - Sayı: 3

Granulomatous prostatitis diagnosed during intravesical BCG treatment

Mesane içi BCG tedavisi sırasında tanısal granülomatöz prostatit

Pages
204–206
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This diagnosis was performed histopathologically, and the treat- ment of the patient proved successful.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The bladder biopsy of 70-year-old man who had a bladder cancer diagnosis three years prior indicated a car- cinoma in situ (CIS).
📊
Key Findings & Data:An antituberculosis treatment was initiated because the PPD test result was 25 mm and the QuantiFERON test was positive.
💡
Conclusion & Impact:This diagnosis was performed histopathologically, and the treat- ment of the patient proved successful.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The bladder biopsy of 70-year-old man who had a bladder cancer diagnosis three years prior indicated a car- cinoma in situ (CIS). Intravesical immunotherapy treatment was initiated. After severe dysuria symptoms, the immunotherapy treatment dosage was lowered. The treatment was then halted due to the progression of symptoms. A biopsy was performed due to prostate spesific antigen (PSA) and digital rectal examination abnormalities and indicated granulomatous prostatitis. An antituberculosis treatment was initiated because the PPD test result was 25 mm and the QuantiFERON test was positive. After one month, the patient’s PSA levels had been reduced, and his symptoms had regressed. The symptoms of severe dysuria, sterile pyuria, abnormal digital rectal examination and high PSA levels during intravesical BCG treatment led us to deduce a diagnosis of granulomatous prostatitis. This diagnosis was performed histopathologically, and the treat- ment of the patient proved successful.

Özet

Üç sene önce mesane tümörü tanısı alan 70 yaşında erkek hastanın yapılan kontrol sistoskopisinde mesane- sindeki hiperemik alanlardan yapılan biyopsi patolojisi karsinoma in situ (CIS) olarak raporlandı.Hastaya intravezikal immunoterapi tedavisi başlandı. Mesane içi BCG tedavisi esnasında hastanın ciddi dizüri şika- yetleri olması nedeniyle düşük doz mesane içi BCG tedavisine geçildi.Hastanın şikayetleri devam edince te- daviye ara verildi. Bu arada yapılan PSA değerinin yüksek çıkması ve rektal muayene anormalliği nedeniyle hastaya prostat biyopsisi yapıldı. Patolojisi granülomatöz prostatit olarak raporlandı. Hastanın PPD değeri- nin 25 mm çıkması ve quantiferon testinin pozitif olması nedeniyle hastaya antitüberküloz tedavi başlandı. Bir aylık tedavi sonrasında PSA değerlerinde düşme ve hastanın kliniğinde düzelme görüldü. Mesane içi BCG tedavisi esnasında görülen ciddi dizüri şikayetleri, steril piyüri, rektal muayene anormalliği ve PSA yükselmesi granülomatöz prostatiti akla getirmelidir. Tanının histopatolojik olarak konulduğu ve medical tedaviden fayda gördüğü unutulmamalıdır.

🔖

Cite This Article

OKÇELİK, S., SOYDAN, H., YILMAZ, İ., YILMAZ, Ö., ATEŞ, F., KARADEMİR, K. (2013). Granulomatous prostatitis diagnosed during intravesical BCG treatment. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 39 - Sayı: 3, 204–206. https://ajindex.com/articles/328036

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Tanner FH, McDonald JR. Granulomatous prostatitis:a histologic study of a group of granulomatous lesions collected from prostate glands. Arch Pathol Lab Med 1943;36:358-70. 2.Eyre RC, Aaronson AG, Weinstein BJ. Palisading granulomas of the prostate associated with prior prostatic surgery. J Urol 1986;136:121-2. 3.LaFontaine PD, Middleman BR, Graham SD Jr, Sanders WH. Incidence of granulomatous prostatitis and acid-fast bacilli after intravesical BCG therapy. Urology 1997;49:3636. [CrossRef] 4.Saw KC, Hartfall WG, Rowe RC. Tuberculous prostatitis: nodula- rity may simulate malignancy. Br J Urol 1993;72:249. 5.Herranz Amo F, Verdú Tartajo F, Díez Cordero JM, Bueno Chomón G, Leal Hernández F, Bielsa Carrillo A, et al. Non-specific granu- lomatous prostatitis diagnosed with ultrasonography-guided trans- rectal biopsy. Actas Urol Esp 1998;22:757-61. 6. Stillwell TJ, Engen DE, Farrow GM. The clinical spectrum of gra- nulomatous prostatitis: a report of 200 cases. J Urol 1987;138:320-3. 7.Mohan H, Bal A, Punia RP, Bawa AS. Granulomatous prostatitis-- an infrequent diagnosis. Int J Urol 2005;12:474-8. [CrossRef] 8.Oates RD, Stilmant MM, Freedlund MC, Siroky MB. Granulo- matous prostatitis following bacillus Calmette-Guerin immunot- herapy of bladder cancer. J Urol 1998;140:751-4. 9. Speights VO Jr, Brawn PN. Serum prostate specific antigen levels in non-specific granulomatous prostatitis. Br J Urol 1996;77:408-10. [CrossRef] 10. Beltrami P, Ruggera L, Cazzoletti L, Schiavone D, Zattoni F. Are prostate biopsies mandatory in patients with prostate-specific an- tigen increase during intravesical immuno- or chemotherapy for superficial bladder cancer? Prostate. 2008;68:1241-7. [CrossRef] 11. Leibovici D, Zisman A, Chen-Levyi Z, Cypele H, Siegel YI, Fa- itelovich S, et al. Elevated prostate specific antigen serum levels after intravesical instillation of bacillus Calmette-Guerin. J Urol 2000;164:1546-9.